News series “German IPOs & IBOs in the spotlight” – 01/2018
Wiesbaden, 14 June 2018 – By the end of 2017, capital market circles had already predicted that 2018 would probably be the best year for IPOs since the dotcom bubble at the turn of the millennium. Since the beginning of the year, eight German companies have already successfully floated on the stock exchange. One of them is Siemens Healthineers, the medical technology subsidiary of Siemens. With a proceeds of EUR 4.2 billion, the company is the fourth largest new issue in Germany since 2000. Siemens Healthineers is to be admitted to the TecDAX in mid-June. Not only the Siemens subsidiary, however, also the subsidiary of Deutsche Bank, DWS, was successfully listed on the stock exchange in 2018. In March of this year, the issue proceeds amounted to EUR 1.4 billion instead of the originally hoped-for EUR 2 billion.
Dermapharm Holding SE also had reason to be pleased. Despite the difficult market environment and the uncertainty prevailing on the financial markets at the time of the initial public offering, the company has brought its IPO into dry hands. Dermapharm achieved a total of EUR 377 million with the IPO. In addition, further IPO candidates are currently planning to go public. On June 5, Akasol GmbH announced that preparations were being made in Darmstadt for an IPO in June. Akasol manufactures high-performance battery systems for buses and commercial vehicles. That this industry works well on the stock market we have already seen at the battery company Voltabox, which made a brilliant stock market debut in 2017 and started the year with strong price gains on the Frankfurt Stock Exchange.
Always well advised with cometis
If you are planning an IPO or if you still require support for your IPO, cometis AG is your reliable partner for your IPO communication. Find out more about our wide range of IPO communications in the IPO section of our website.